Wed.Jul 31, 2024

article thumbnail

STAT+: Mount Sinai mounted aggressive campaign to stifle debate over revelations about its controversial brain research

STAT

Mount Sinai, a leading hospital network in New York City, has mounted an extraordinary behind-the-scenes campaign to blunt the fallout over revelations about its controversial research project in which brain biopsies are taken from patients undergoing deep brain stimulation, STAT has learned. That has included not only enlisting its own patients to defend the research but also seeking to stop a professional society of neurosurgeons from issuing a statement that could have jeopardized the researc

article thumbnail

3 Big Pharma cancer drugs facing inflation penalties

PharmaVoice

The U.S. government will demand payment from Big Pharma to make up for dozens of drugs with prices that rose faster than the rate of inflation.

246
246
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Vision loss and high cholesterol identified as risk factors for dementia

STAT

Untreated vision loss and high LDL cholesterol have been added as two new potentially modifiable risk factors for dementia in a report released Wednesday by the Lancet Commission. These new additions join 12 other risk factors outlined by the commission, affiliated with University College London, in previous reports on dementia prevention, intervention, and care in 2017 and 2020.

Diabetes 363
article thumbnail

Pharmacy contract delays causing 'stress, uncertainty and closures'

The Pharmacist

More and more pharmacies are closing as a six-month delay to the community pharmacy contract means core funding has still not been uplifted since 2019. Contractors told The Pharmacist that they struggle to keep up with increased demand for services and the knock-on impact of pressure elsewhere in the health system, while being unable to pay their […] The post Pharmacy contract delays causing 'stress, uncertainty and closures' appeared first on The Pharmacist.

article thumbnail

Why Every Small Business Needs an HCM Solution: A Comprehensive Guide

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

article thumbnail

What I learned about ultra-processed foods from stuffing my face at the world’s leading food technology event

STAT

CHICAGO — “Buttery Biscuits & Hot Honey Gravy,” mushroom jerky, soy chicken nuggets, strawberry champagne donuts, plant-based frozen yogurt and buñuelos, white cheddar cheese puffs, chocolatey cookie dippers, egg-free Spanish cheesecake, plant-based chorizo-style empanadas … I was at the annual gathering of food technologists this month to learn about, well, food technology, and I had found myself in the exhibit hall, testing how much I could eat before needi

362
362
article thumbnail

Biotech startup Airna raises $60M for RNA editing medicines

BioPharma Dive

Launched last September, the company is working on a treatment for alpha-1 antitrypsin deficiency, which it said could enter the clinic in 2025.

117
117

More Trending

article thumbnail

Vertex eyes FDA decision on non-opioid pain drug in January

pharmaphorum

Vertex has filed for FDA approval of its non-opioid pain drug suzetrigine, starting the clock ticking on a review that should be completed early next year

114
114
article thumbnail

Biden administration should push for addiction medication in recovery houses, groups say

STAT

The Biden administration isn’t doing enough to ensure people living in recovery housing have access to gold-standard addiction medications like methadone and buprenorphine , according to a coalition of health care, harm reduction, and addiction recovery groups.  The discrimination that people often face when seeking treatment using methadone or buprenorphine, the groups say, is especially pronounced within recovery housing facilities, which typically offer lodging coupled with counse

319
319
article thumbnail

Fischer Medical Ventures partners with Bio Angle Vacs Sdn Bhd’s in science, technology and marketing

Express Pharma

Fischer Medical Ventures (Fischer MV), confirmed its investment and collaboration with Bio Angle Vacs Sdn Bhd (BAV), a biotechnology company in Malaysia that develops, manufactures and distributes vaccines to small and large-scale farming owners worldwide; focusing on health and disease prevention for livestock and aquaculture. BAV have to date secured a total of USD 83 million annual sales contracts from China, Nigeria, Kenya, Chad, Uganda, Uzbekistan and Indonesia for its range of innovative,

Vaccines 105
article thumbnail

Opinion: Cost counseling and stewardship need to be part of medical school curricula

STAT

In my third week as a medical intern, I learned a vital lesson about the realities of everyday medicine that textbooks and professors hadn’t taught me: how profoundly the financial cost of care affects patients. I was caring for a man admitted to the hospital with uncontrolled atrial fibrillation, an irregular and often rapid heartbeat. After much deliberation, I prescribed a new anticoagulant to prevent the formation of blood clots in his heart, instructed him to continue using his curre

article thumbnail

Best Practices to Streamline Compensation Management: A Foundation for Growth

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

article thumbnail

Frontiers Health 2024: Connecting changemakers, cultivating health system change

pharmaphorum

Frontiers Health 2024 is a platform connecting innovators and changemakers in the life sciences industry to cultivate positive changes in health systems. Discover the latest trends and insights in healthcare innovation.

115
115
article thumbnail

STAT+: Pharmalittle: We’re watching GLP-1 drug data in Alzheimer’s, a flu shot push for livestock workers, and more

STAT

Good morning, folks! The Dean of Pharmalittle University, Ed Silverman, is out on vacation. I also recently went on a mini-vacation, traveling up to a lake house for fun with friends. I’ll be writing my “What I did on summer vacation” essay later this week. But first, the news. … A new study suggests that an older GLP-1 drug may help protect the brains of people with early Alzheimer’s disease, supporting the case for further research on this class of medication

Vaccines 261
article thumbnail

Magazine: Left in limbo: when pharma halts rare disease research

Pharmaceutical Technology

Gene therapy research is expensive. Biotechs invest millions of dollars in early research to develop therapies for conditions that might be rare. But when funds are limited and the market potential is dim, such programs are often abandoned by companies, leaving patients and investigators in a bind.

98
article thumbnail

The debate over how long to use Alzheimer’s drugs

STAT

Good morning. We have a new investigation out today about how Mount Sinai in New York mounted an aggressive campaign to stifle debate over its controversial brain research. Check it out here. And let’s get into the biotech news.

article thumbnail

Enhance Healthcare Efficiency With Top Payroll & HCM Services

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

article thumbnail

NPPA monitors the prices of scheduled as well as non-scheduled medicines under DPCO, 2013

Express Pharma

According to the statement published by PIB, The National Pharmaceutical Pricing Authority (NPPA) is actively overseeing the pricing of both scheduled and non-scheduled medicines under the Drugs (Prices Control) Order, 2013 (DPCO, 2013). The NPPA ensures that companies adhere to permissible pricing limits, taking action against those who violate these rules.

article thumbnail

Morning Rounds: Grindr gets into health care lobbying

STAT

Want to stay on top of health news?  Sign up  to get our Morning Rounds newsletter in your inbox. Surprisingly, a story by my colleagues Nick Florko and Sarah Owermohle about how Grindr hired a Washington lobbyist is NOT the first time the, uh, “social networking app” (their words!) has appeared in STAT reporting. A quick Google search tells me that the word first appeared in an early episode of The Readout LOUD.

261
261
article thumbnail

GSK cuts vaccine forecasts, while predicting faster overall growth

BioPharma Dive

Several factors are slowing U.S. sales of Shingrix, the shingles vaccine that's become one of the British pharma's top sellers.

Vaccines 113
article thumbnail

Viking Therapeutics’ obesity drug could become direct competitor to Eli Lilly’s tirzepatide: GlobalData

Express Pharma

The obesity market continues to expand, but therapeutic options remain limited and shortages in supply continue. This creates a significant opportunity for new entrants. Numerous companies are exploring potential breakthrough mechanisms of action beyond GLP-1R agonists, while others are focusing on the synergistic effects of targeting multiple receptors to enhance the benefits of GLP-1R agonists.

article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

GP contract uplift 'intended' to cover 6% pay rise for practice-employed pharmacists

The Pharmacist

Pharmacists employed directly by general practices should receive a 6% pay uplift following the recommendations of the Review Body on Doctors’ and Dentists’ Remuneration (DDRB). But this may vary from practice to practice, since as independent contractors, each GP employer will decide whether to pass on the 6% uplift in salary funding to their employees. […] The post GP contract uplift 'intended' to cover 6% pay rise for practice-employed pharmacists appeared first on The Pharmac

94
article thumbnail

Lupin secures tentative U.S. FDA approval for generic HIV treatment under PEPFAR

Express Pharma

Global pharma major Lupin (Lupin) today announced that it has received tentative approval from the United States Food and Drug Administration (U.S. FDA) under the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) for its Abbreviated New Drug Application for Emtricitabine and Tenofovir Alafenamide Tablets, 200 mg/25 mg, to market a generic equivalent of Descovy Tablets, 200 mg/25 mg, of Gilead Sciences, Inc.

98
article thumbnail

How biometrics applications are contributing to clinical trial diversity

pharmaphorum

Ensuring equitable access to medications remains a fundamental commitment for many pharmaceutical companies to their customers, patients, and stakeholders. However, there has been a discernible shift recently in the timing of access discussions.

article thumbnail

Government schemes bolster startup growth in India’s pharmaceutical sector

Express Pharma

The Government of India has rolled out several initiatives to boost startups, with a significant focus on the pharmaceutical sector. The Department of Pharmaceuticals recently launched the Scheme for Promotion of Research and Innovation in Pharma-MedTech sector (PRIP), which targets startups through its Component BIII. Out of 125 research projects identified in six priority areas, 50 are specifically designated for pharmaceutical startups.

105
105
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

GSK raises forecasts for 2024, but shares slide

pharmaphorum

GSK raises 2024 forecasts on a strong Q2 led by HIV and cancer drugs, but its shares weakened on litigation concerns and weaker vaccine expectations

Vaccines 107
article thumbnail

August Pharmacy First threshold reduced to 15

The Pharmacist

Community pharmacies will only need to perform 15 Pharmacy First clinical pathway consultations in August to meet the minimum threshold, rather than the 20 originally set for the month. This comes as recent data has revealed that one in five community pharmacies participating in Pharmacy First in England failed to meet the minimum threshold of […] The post August Pharmacy First threshold reduced to 15 appeared first on The Pharmacist.

article thumbnail

Patients resist Novo Nordisk plan to stop making Levemir

pharmaphorum

Patient advocacy group APIC has started a campaign to stop Novo Nordisk from following through on a plan to stop making insulin product Levemir

111
111
article thumbnail

FDA approves J&J’s multiple myeloma therapy

Pharmaceutical Technology

The US FDA has granted approval for Johnson & Johnson’s (J&J) DARZALEX FASPRO for treating newly diagnosed multiple myeloma (NDMM).

97
article thumbnail

After EU setback, Eisai/Biogen build case for Leqembi

pharmaphorum

Eisai, Biogen report data showing benefit of Alzheimer's disease therapy Leqembi builds with time, with no increase in safety risk

107
107
article thumbnail

MSD reports net income of $5.4bn in Q2 2024

Pharmaceutical Technology

MSD has reported a net income on a GAAP basis of $5.4bn for Q2 2024 compared to the net loss of $5.9bn in the same quarter of 2023.

98
article thumbnail

EPSRC launches two new hubs to transform early disease diagnosis in the UK

Pharma Times

Quantum-based technologies will explore infectious diseases, cancer and dementia

115
115
article thumbnail

Pfizer’s Q2 2024 net income attributable to shareholders down 98%

Pharmaceutical Technology

Pfizer has posted a 98% decrease in net income attributable to shareholders of $41m for Q2 2024, compared to $2.3bn in Q2 2023.

98
article thumbnail

Best Practices for Drug Patent Portfolio Management: Maximizing Value in Pharmaceutical Innovation

Drug Patent Watch

In the high-stakes world of pharmaceutical development, effective patent portfolio management can mean the difference between blockbuster success and costly […] Source

83
article thumbnail

Apollo and Oxford University enter drug discovery and development collaboration

Pharma Times

The latest collaboration marks Apollo’s sixth agreement with a research institution

111
111